Guidelines on the Treatment of Chronic Coinfection by Trypanosoma cruzi and HIV Outside Endemic Areas

REFERENCES

• Organización Panamericana de la salud (OPS/OMS). Estimaci6n cuantitativa de la Enfermedad de Chagas en las Americas. OPS/HDM/CD/425-06. Montevideo, Uruguay; 2006.
   Google Scholar
• Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388–1402.
   PubMed Web of Science ®Google Scholar
• Control and prevention of Chagas disease in Europe. Report of a WHO Informal Consultation aointly organized by WHO headquarters and the WHO Regional Office for Europe). Geneva, Switzerland; December 17–18, 2009. WHO/HTM/NTD/IDM/2010.1. 2010.
   Google Scholar
• Schmunis GA, Yadon ZE. Chagas disease: a Latin Ameri-can health problem becoming a world health problem. Acta Trop. 2010;115:14–21.
   PubMed Web of Science ®Google Scholar
• Instuto Nacional de Estadistica. http://www.ine.es/jaxi/tabla.do.
   Google Scholar
• Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22–27.
   PubMed Web of Science ®Google Scholar
• Munoz J, Gomezi Prat J, Gallego M, et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 2009;111:51–55.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Guardado A, Alvarez VA, Rodriguez Perez M, et al. Screening for Chagas' disease in HIV-positive immigrants from endemic areas. Epidemiol Infect. 2010:1–5.
   Web of Science ®Google Scholar
• Perez-Ayala A, Pérez-Molina JA, Norman F, et al. Chagas disease in Latin American migrants: a Spanish chal-lenge [published online ahead of print December 14, 2010]. Clin Microbiol Infect. 2011;17(7):1108–1113. doi:10.1111/j.1469-0691.2010.03423.x.
   PubMed Web of Science ®Google Scholar
• AIDS epidemic update. UNAIDS/09.36E /JC1700E. 2009. http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf.
   Google Scholar
• Vigilancia epidemiológica del VIH en Espana. Valoración de los nuevos diagn6sticos de VIH en Espana a partir de los sistemas de notificaci6n de casos de la CCAA. Periodo 2003–2008. Actualización 30 de junio de 2009. www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/NuevosdiagVIH2009.pdf. 2009.
   Google Scholar
• Almeida EA, Lima JN, Lages-Silva E, et al. Chagas' disease and HIV co-infection in patients without effective antiretro-viral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg. 2010;104:447–452.
   PubMed Web of Science ®Google Scholar
• Diez MS, Nocito I, de Frade AR, Cappello SG, Guillen SM, Montero A. [Serological evidence of cytomegalovirus, hepatitis B and C, Epstein-Barr virus, Toxoplasma Trypanosoma cruzi and Treponema pallidum in HIV infected patients]. Medicina ('3 Aires). 2001;61: 378–380.
   Google Scholar
• Dolcini G, Ambrosioni J, Andreani G, Pando MA, Martinez Peralta L, Benetucci J. [Prevalence of human immunode-ficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center]. Rev Argent MicrobioL 2008;40:164–166.
   PubMed Web of Science ®Google Scholar
• Kish MA. Guide to development of practice guidelines. Clin Infect Dis. 2001;32:851–854.
   PubMed Web of Science ®Google Scholar
• Karp CL, Auwaerter PG. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis. 2007;45:1208–1213.
   PubMed Web of Science ®Google Scholar
• Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis. 2009;9:324–330.
   PubMed Web of Science ®Google Scholar
• Sartori AM, Neto JE, Nunes EV, et al. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis. 2002186: 872–875.
   Google Scholar
• Idemyor V. Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans. HIV Clin Trials. 2007;8:246–253.
   PubMed Web of Science ®Google Scholar
• Kjetland EF, Ndhlovu PD, Gomo E, et al. Association between genital schistosomiasis and HIV in rural Zimba-bwean women. AIDS. 2006;20:593–600.
   PubMed Web of Science ®Google Scholar
• Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis. 2008;12:587–592.
   PubMed Web of Science ®Google Scholar
• Del Castillo M, Mendoza G, Oviedo J, Perez Bianco RP, Anselmo AE, Silva M. AIDS and Chagas' disease with central nervous system tumor-like lesion. Am J Med. 1990;88:693–694.
   PubMed Web of Science ®Google Scholar
• Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes-Araujo FR, Rocha A. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis. 1997;25: 1397–1400.
   PubMed Web of Science ®Google Scholar
• Gallo P, Fabiao Neto OM, Suarez JM, Borba RP. Acute central nervous system infection by Trypanosoma cruzi and AIDS. Arq Neuropsiquiatr 1992;50:375–377.
   PubMedGoogle Scholar
• Rocha A, de Meneses AC, da Silva AM, et al. Pathology of patients with Chagas' disease and acquired immunodefi-ciency syndrome. Am J Trop Med Hyg. 1994;50:261–268.
   PubMed Web of Science ®Google Scholar
• Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanoso-miasis) in patients with HIV/AIDS. Ann Trop Med Parasitol. 2007;101:31–50.
   PubMed Web of Science ®Google Scholar
• Sartori AM, Caiaffa-Filho HH, Bezerra RC, do SGC, Lopes MH, Shikanai-Yasuda MA. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease. Am J Trop Med Hyg. 2002;67:521–523.
   PubMed Web of Science ®Google Scholar
• Organización Panamericana de la Salud. Definición de la OMS de caso de infecci6n por el VIH a efectos de vigi-lancia y revision de la estadificación clinica y de la clasifi-cación inmunológica de la enfermedad relacionada con el VIH en adultos y ninos. 2009. OPS/FCH/HI/04-09.E.
   Google Scholar
• Sartori AM, Shikanai-Yasuda MA, Amato Neto V, Lopes MH. Follow-up of 18 patients with human immunodefi-ciency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin Infect Dis. 1998;26:177–179.
   PubMed Web of Science ®Google Scholar
• Almeida EA, Ramos Junior AN, Correia D, Shikanai-Yasuda MA. [Brazilian Network of Attention and Stud-ies on Trypanosoma cruzi/HIV co-infection and others immunossupression conditions]. Rev Soc Bras Med Trop. 2009;42:605–608.
   PubMed Web of Science ®Google Scholar
• Sica RE, Gargiullo G, Papayanis C. Tumour-like chagasic encephalitis in AIDS patients: an atypical presentation in one of them and outcome in a small series of cases. Arq Neuropsiquiatr 2008;66:881–884.
   PubMed Web of Science ®Google Scholar
• Pagano MA, Segura MJ, Di Lorenzo GA, et al. Cerebral tumor-like American trypanosomiasis in acquired immunodeficiency syndrome. Ann NeuroL 1999;45:403–406.
   PubMed Web of Science ®Google Scholar
• Sartori AM, Lopes MH, Benvenuti LA, et al. Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood. Am J Trop Med Hyg. 1998;59:784–786.
   PubMed Web of Science ®Google Scholar
• [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection]. Rev Soc Bras Med Trop. 2006;39:392–415.
   PubMed Web of Science ®Google Scholar
• Concetti H, Retegui M, Perez G, Perez H. Chagas' disease of the cervix uteri in a patient with acquired immunodefi-ciency syndrome. Hum PathoL 2000;31:120–122.
   PubMed Web of Science ®Google Scholar
• dos Santos Sde S, Almeida GM, Monteiro ML, et al. Ocular myositis and diffuse meningoencephalitis from Trypano-soma cruzi in an AIDS patient. Trans R Soc Trop Med Hyg. 1999;93:535–536.
   PubMed Web of Science ®Google Scholar
• Iliovich E, Lopez R, Kum M, Uzandizaga G. [Spontane-ous chagasic peritonitis in a patient with AIDS]. Medicina (B Aires). 1998;58:507–508.
   PubMed Web of Science ®Google Scholar
• Oelemann W, Velasquez JN, Carnevale S, Besasso H, Teixeira MG, Peralta JM. Intestinal Chagas' disease in patients with AIDS. AIDS. 2000;14:1072–1073.
   PubMed Web of Science ®Google Scholar
• Sartori AM, Sotto MN, Braz LM, et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg. 1999;93:631–632.
   PubMed Web of Science ®Google Scholar
• Ferreira MS, Nishioka Sde A, Rocha A, et al. Acute fatal Trypanosoma cruzi meningoencephalitis in a human immu-nodeficiency virus-positive hemophiliac patient. Am J Trop Med Hyg. 1991;45:723–727.
   PubMed Web of Science ®Google Scholar
• Solari A, Saavedra H, Sepulveda C, et al. Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. Clin Infect Dis. 1993;16: 255–259.
   PubMed Web of Science ®Google Scholar
• Valerga M, Bases O, Martin M, Papucci T. [Multifocal encephalitis in an AIDS patient]. Enferm Infecc Microbiol Cl/n. 2005;23:569–570.
   PubMed Web of Science ®Google Scholar
• Corti M, Yampolsky C. Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome. Rev Soc Bras Med Trop. 2006;39:85–88.
   PubMed Web of Science ®Google Scholar
• Lopez MO. [Three-year survival of a patient with HIV and chagasic meningoencephalitis: case report]. Rev Chilena InfectoL 2010;27:160–164.
   PubMed Web of Science ®Google Scholar
• Flores-Chavez M, De Fuentes 1, Garate T, Canavate C. Diagnóstico de laboratorio de la enfermedad de Chagas importada. Enferm Infecc Microbiol Cl/n. 2007;25 (Suppl 3):29–37.
   Google Scholar
• Murcia L, Carrilero B, Munoz MJ, lborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother 2010;65:1759–1764.
   PubMed Web of Science ®Google Scholar
• Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5:e931.
   PubMed Web of Science ®Google Scholar
• Gascon J. [Diagnosis and treatment of imported Chagas disease]. Med Clin (Barc). 2005;125:230–235.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo GA, Pagano MA, Taratuto AL, Garau ML, Meli FJ, Pomsztein MD. Chagasic granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings. J Neuroimag-ing. 1996;6:94–97.
   PubMed Web of Science ®Google Scholar
• Verdu J, De Paz F, Castano V, Torrus D, Reus S. Reac-tivation of Chagas disease with central nervous system involvement: peripheral blood smear evidence. Int J Infect Dis. 2009;13:e527–8.
   PubMed Web of Science ®Google Scholar
• Burgos JM, Diez M, Vigliano C, et al. Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactiva-tion after heart transplantation. Clin Infect Dis. 2010;51:4 85–495.
   PubMed Web of Science ®Google Scholar
• Corti M, Trione N, Corbera K, Vivas C. [Chagas disease: another cause of cerebral mass occurring in patients with acquired immunodeficiency syndrome]. Enferm Infecc Microbiol Cl/n. 2000;18:194–196.
   PubMedGoogle Scholar
• Lages-Silva E, Ramirez LE, Silva-Vergara ML, Chiari E. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clin Infect Dis. 2002;34: 118–123.
   PubMed Web of Science ®Google Scholar
• Lazo JE, Meneses AC, Rocha A, et al. [Toxoplasmic and chagasic meningoencephalitis in patients with human immunodeficiency virus infection: anatomopathologic and tomographic differential diagnosis]. Rev Soc Bras Med Trop. 1998;31:163–71.
   PubMedGoogle Scholar
• Oddo D, Casanova M, Acuna G, Ballesteros J, Morales B. Acute Chagas' disease (Trypanosomiasis americana) in acquired immunodeficiency syndrome: report of two cases. Hum Pathol. 1992;23:41–44.
   PubMed Web of Science ®Google Scholar
• Almeida EA, Silva EL, Guariento ME, Souza ML, Aoki FH, Pedro Rde J. [Fatal evolution of Chagas'disease/AIDS co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy]. Rev Soc Bras Med Trop. 2009;42:199–202.
   PubMed Web of Science ®Google Scholar
• Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA. 2007;298:2171–2181.
   PubMed Web of Science ®Google Scholar
• Perez-Molina JA, Perez-Ayala A, Moreno S, Fernandez-Gonzalez MC, Zamora J, Lopez-Velez R. Use of benz-nidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J Antimicrob Chemother. 2009;64:1139–1147.
   PubMed Web of Science ®Google Scholar
• Rodrigues Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002;97:3–24.
   PubMed Web of Science ®Google Scholar
• Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benz-nidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144:724–734.
   PubMed Web of Science ®Google Scholar
• Reyes PA, Vallejo M. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infec-tion). Cochrane Database Syst Rev. 2005:CD004102.
   PubMed Web of Science ®Google Scholar
• Murta SM, Gazzinelli RT, Brener Z, Romanha AJ. Molecu-lar characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurti-mox. Mol Biochem Parasitol. 1998;93:203–214.
   PubMed Web of Science ®Google Scholar
• Villarreal D, Nirde P, Hide M, Barnabe C, Tibayrenc M. Differential gene expression in benznidazole-resistant Try-panosoma cruzi parasites. Antimicrob Agents Chemother 2005;49:2701–2709.
   PubMed Web of Science ®Google Scholar
• Castro JA, de Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American trypanoso-miasis). Hum Exp Toxicol. 2006;25:471–479.
   PubMed Web of Science ®Google Scholar
• Pinazo MJ, Munoz J, Posada E, et al. Tolerance of benzni-dazole in treatment of Chagas' disease in adults. Antimi-crob Agents Chemother 2010;54:4896–4899.
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adoles-cents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infec-tious Diseases Society of America. MMWR Recomm Rep. 2009;58:1-207; quiz CE1–4.
   Google Scholar
• [2008 prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan.]. Enferm Infecc Microbiol Cl/n. 2008;26:437–464.
   Google Scholar
• Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis. 2010;51:e69–75.
   PubMed Web of Science ®Google Scholar
• de Almeida EA, Silva EL, Guariento ME, Aoki FH, Pedro Rde J. Aetiological treatment with itraconazole or keto-conazole in individuals with Trypanosoma cruzi/HIV co-infection. Ann Trop Med Parasitol. 2009;103:471–476.
   PubMed Web of Science ®Google Scholar
• Pinazo MJ, Espinosa G, Gallego M, Lopez-Chejade PL, Urbina JA, Gascon J. Successful treatment with posacon-azole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg. 2010;82:583–587.
   PubMed Web of Science ®Google Scholar
• Boffito M, Acosta E, Burger D, et al. Therapeutic drug monitoring and drug-drug interactions involving antiretro-viral drugs. Anti vir Ther 2005;10:469–477.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Guardado A, Tuset M, Asensi V, Miro JM. [Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report]. Med Clin (Barc). 2010;137:278–279.
   PubMed Web of Science ®Google Scholar
• Dooley KE, Flexner C, Andrade AS. Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. J Infect Dis. 2008;198:948–961.
   PubMed Web of Science ®Google Scholar
• Gura para vigilancia, prevención, control y manejo clinico de la Enfermedad de Chagas aguda transmitida por alimentos (PAHO/HSD/CD/539.09). Rio de Janeiro: PANAFTOSA-VP/ OPAS/OMS: Organización Panamericana de la salud; 2009.
   Google Scholar
• Pinazo MJ, Miranda B, Rodriguez-Villar C, et al. Recom-mendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando). 2011;25: 91–101.
   PubMedGoogle Scholar
• REAL DECRETO 1088/2005, de 16 de septiembre, por el que se establecen los requisitos tecnicos y condiciones mil-limas de la hemodonación y de los centros y servicios de transfusi6n. Ministerio de Sanidad y Consumo. In: Boletin Oficial del Estado, numero 225; 2005.
   Google Scholar
• Villar JC, Marin-Neto JA, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infec-tion. Cochrane Database Syst Rev. 2002:CD003463.
   PubMedGoogle Scholar
• Perez-Ramirez L, Barnabe C, Sartori AM, et al. Clinical analysis and parasite genetic diversity in human immu-nodeficiency virus/Chagas' disease coinfections in Brazil. Am J Trop Med Hyg. 1999;61:198–206.
   PubMed Web of Science ®Google Scholar
• Galhardo MC, Martins IA, Hasslocher-Moreno A, et al. [Reactivation of Trypanosoma cruzi infection in patients with acquired immunodeficiency syndrome]. Rev Soc Bras Med Trop. 1999;32:291–294.
   PubMedGoogle Scholar
• Munoz J, Coll O, Juncosa T, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48:1736–1740.
   PubMed Web of Science ®Google Scholar
• Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del-Castillo JI, et al. [Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community]. Enferm Infecc Microbiol Cl/n. 2008;26:609–613.
   PubMed Web of Science ®Google Scholar
• Soriano Arandes A, Munoz Gutierrez J, Verges Navarro M, Castells Domenech C, Portus Vinyeta M, Gascon Brustenga J. Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain). Acta Trop. 2009;112:228–230.
   PubMed Web of Science ®Google Scholar
• Brutus L, Castillo H, Bernal C, et al. Detectable Trypano-soma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg. 2010;83:1044–1047.
   PubMed Web of Science ®Google Scholar
• Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmis-sion. Rev Soc Bras Med Trop. 2009;42:484–487.
   PubMed Web of Science ®Google Scholar
• Bisio M, Cura C, Duffy T, et al. Trypanosoma cruzi discrete typing units in Chagas disease patients with HIV co-infection. Rev Biomed. 2009;20:166–178.
   Google Scholar
• Freilij H, Altcheh J, Muchinik G. Perinatal human immuno-deficiency virus infection and congenital Chagas' disease. Pediatr Infect Dis J. 1995;14:161–162.
   PubMed Web of Science ®Google Scholar
• Nisida IV, Amato Neto V, Braz LM, Duarte MI, Umezawa ES. A survey of congenital Chagas' disease, carried out at three health institutions in Sao Paulo City, Brazil. Rev lnst Med Trop Sao Paulo. 1999;41:305–311.
   PubMedGoogle Scholar
• Scapellato PG, Bottaro EG, Rodriguez-Brieschke MT. Mother-child transmission of Chagas disease: Could coin-fection with human immunodeficiency virus increase the risk? Rev Soc Bras Med Trop. 2009;42: 107–109.
   PubMed Web of Science ®Google Scholar
• Bern C, Verastegui M, Gilman RH, et al. Congenital Try-panosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis. 2009;49:1667–1674.
   PubMed Web of Science ®Google Scholar
• Andreani G, Celentano AM, Solana ME, et al. Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi. PLoS One. 2009;4:e8246.
   Google Scholar
• Dolcini GL, Solana ME, Andreani G, et al. Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta. Retro virology. 2008;5:53.
   Google Scholar
• de Toranzo EG, Masana M, Castro JA. Administration of benznidazole, a chemotherapeutic agent against Chagas disease, to pregnant rats. Covalent binding of reactive metabolites to fetal and maternal proteins. Arch Int Pharmacodyn Ther 1984;272:17–23.
   PubMedGoogle Scholar
• Gorla NB, Ledesma OS, Barbieri GP, Larripa IB. Assessment of cytogenetic damage in chagasic children treated with benznidazole. Mutat Res. 1988;206:217–220.
   PubMed Web of Science ®Google Scholar
• Gorla NB, Ledesma OS, Barbieri GP, Larripa IB. Thirteen-fold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox. Mutat Res. 1989;224:263–267.
   PubMed Web of Science ®Google Scholar
• Bittencourt AL, Sadigursky M, Da Silva AA, et al. Evalu-ation of Chagas' disease transmission through breast-feeding. Mem lnst Oswaldo Cruz. 1988;83:37–39.
   PubMedGoogle Scholar
• Bittencourt AL. Possible risk factors for vertical transmis-sion of Chagas' disease. Rev lnst Med Trop Sao Paulo. 199234: 403–408.
   Google Scholar
• Recomendaciones de la SPNS/GESIDA/SEGO/AEP para el seguimiento de la infecci6n por el VIH con relación a la repro-ducci6n, el embarazo y la prevención de la transmisión verti-cal. (Diciembre 2007). www.gesida.seimc.org/pcientifica/index.asp (consultado el 1 de noviembre de 2010). 2007.
   Google Scholar